{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T07:13:07Z","timestamp":1789456387440,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Shanxi Eye Hospital Innovation Fund, China.","award":["C202302"],"award-info":[{"award-number":["C202302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00417-026-07184-6","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T05:57:33Z","timestamp":1774245453000},"page":"2715-2723","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety and efficacy of Esculin and Digitalis glycosides eye drops in individuals with presbyopia"],"prefix":"10.1007","volume":"264","author":[{"given":"Yu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"issue":"1","key":"7184_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2020-000453","volume":"5","author":"S Garima","year":"2020","unstructured":"Garima S, Sima CR, Daniel V et al (2020) Patient-reported outcome measures in presbyopia: a literature review. BMJ Open Ophthalmol 5(1):e000453. https:\/\/doi.org\/10.1136\/bmjophth-2020-000453","journal-title":"BMJ Open Ophthalmol"},{"issue":"4","key":"7184_CR2","doi-asserted-by":"publisher","first-page":"102157","DOI":"10.1016\/j.clae.2024.102157","volume":"47","author":"M Maria","year":"2024","unstructured":"Maria M, Timothy RF, Anitha A et al (2024) BCLA CLEAR presbyopia: epidemiology and impact. Cont Lens Anter Eye: J Bri Cont Lens Assoc 47(4):102157. https:\/\/doi.org\/10.1016\/j.clae.2024.102157","journal-title":"Cont Lens Anter Eye: J Bri Cont Lens Assoc"},{"issue":"6","key":"7184_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/aos.12308","volume":"92","author":"DG Ariana","year":"2014","unstructured":"Ariana DG, William CS, William RB et al (2014) Review of the impact of presbyopia on quality of life in the developing and developed world. Acta Ophthalmol 92(6):497\u2013500. https:\/\/doi.org\/10.1111\/aos.12308","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"7184_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.5301\/ejo.5000554","volume":"25","author":"F Amir","year":"2015","unstructured":"Amir F, Abbas B, Farid K et al (2015) Correlation between ocular biometry and amplitude of accommodation in early presbyopia. Eur J Ophthalmol 25(4):298\u2013301. https:\/\/doi.org\/10.5301\/ejo.5000554","journal-title":"Eur J Ophthalmol"},{"key":"7184_CR5","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.2147\/OPTH.S259011","volume":"15","author":"AK James","year":"2021","unstructured":"James AK, Paul MK, Alexandra D et al (2021) Presbyopia: a review of current treatment options and emerging therapies. Clin Ophthalmol 15:2167\u20132178. https:\/\/doi.org\/10.2147\/OPTH.S259011","journal-title":"Clin Ophthalmol"},{"key":"7184_CR6","doi-asserted-by":"publisher","unstructured":"Negin H, Raid A (2022) Pharmacological treatment of presbyopia: a systematic review. Eur J Transl Myol 32(3). https:\/\/doi.org\/10.4081\/ejtm.2022.10781","DOI":"10.4081\/ejtm.2022.10781"},{"issue":"12","key":"7184_CR7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3760\/ema.j.issn.0412-4081.2010.12.012","volume":"46","author":"YJ Zhen","year":"2010","unstructured":"Zhen YJ, Xiao MQ, Xiao XL (2010) The clinical efficacy and safety study of Esculin and Digitalis glycosides Eye Drops in treating ametropic asthenopia. Chin J Ophthalmol 46(12):1099\u20131103. https:\/\/doi.org\/10.3760\/ema.j.issn.0412-4081.2010.12.012","journal-title":"Chin J Ophthalmol"},{"issue":"1","key":"7184_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10237-023-01767-6","volume":"23","author":"RK Katherine","year":"2024","unstructured":"Katherine RK, AnnMarie H, Silvia SB (2024) A new look at an old problem: 3D modeling of accommodation reveals how age-related biomechanical changes contribute to presbyopia dysfunction. Biomech Model Mechanobiol 23(1):193\u2013205. https:\/\/doi.org\/10.1007\/s10237-023-01767-6","journal-title":"Biomech Model Mechanobiol"},{"key":"7184_CR9","doi-asserted-by":"publisher","unstructured":"Brian MS, Selina RM, Cristos I et al (2024) Understanding perspectives on presbyopia and the use of pilocarpine HCl 1.25% twice daily from participants of the phase 3 VIRGO study. Ophthalmol Ther 13(6):1723\u20131742. https:\/\/doi.org\/10.1007\/s40123-024-00935-w","DOI":"10.1007\/s40123-024-00935-w"},{"issue":"3","key":"7184_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000251","volume":"7","author":"FS Kenneth","year":"2010","unstructured":"Kenneth FS, Douglas GA, David M (2010) Statement: updated guidelines for reporting parallel group randomized trials. PLoS Med 7(3):e1000251. https:\/\/doi.org\/10.1371\/journal.pmed.1000251","journal-title":"PLoS Med"},{"issue":"4","key":"7184_CR11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1001\/jamaophthalmol.2022.0059","volume":"140","author":"OW George","year":"2022","unstructured":"George OW, Francis WP, David W et al (2022) Safety and efficacy of AGN-190584 in individuals with presbyopia: the GEMINI 1 phase 3 randomized clinical trial. JAMA Ophthalmol 140(4):363\u2013371. https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.0059","journal-title":"JAMA Ophthalmol"},{"issue":"253","key":"7184_CR12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ajo.2023.05.008","volume":"09","author":"K Shane","year":"2023","unstructured":"Shane K, Sherif M, Majid M (2023) Safety and efficacy of twice-daily pilocarpine HCl in presbyopia: the Virgo phase 3, randomized, double-masked, controlled study. Am J Ophthalmol 09(253):189\u2013200. https:\/\/doi.org\/10.1016\/j.ajo.2023.05.008","journal-title":"Am J Ophthalmol"},{"key":"7184_CR13","doi-asserted-by":"publisher","unstructured":"James SW, Leon ND, Amy LS (2023) New insights into presbyopia: the impact of correction strategies. BMJ Open Ophthalmol 8(1). https:\/\/doi.org\/10.1136\/bmjophth-2022-001122","DOI":"10.1136\/bmjophth-2022-001122"},{"issue":"12","key":"7184_CR14","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41433-020-01391-z","volume":"35","author":"SK Michael","year":"2021","unstructured":"Michael SK, Stella MR, Jerry MS et al (2021) Topical lipoic acid choline ester eye drop for improvement of near visual acuity in subjects with presbyopia: a safety and preliminary efficacy trial. Eye 35(12):3292\u20133301. https:\/\/doi.org\/10.1038\/s41433-020-01391-z","journal-title":"Eye"},{"issue":"12","key":"7184_CR15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/s1529-1839(02)70311-0","volume":"73","author":"KJ Ciuffreda","year":"2002","unstructured":"Ciuffreda KJ (2002) The scientific basis for and efficacy of optometric vision therapy in nonstrabismic accommodative and vergence disorders. Optometry 73(12):735\u2013762. https:\/\/doi.org\/10.1016\/s1529-1839(02)70311-0","journal-title":"Optometry"},{"issue":"1","key":"7184_CR16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/j.jcrs.0000000000001313","volume":"50","author":"WL Chris","year":"2024","unstructured":"Chris WL, Milton MH, Eugene BM et al (2024) Pilocarpine HCl 1.25% for treatment of presbyopia after laser vision correction: pooled analysis of two phase 3 randomized trials (GEMINI 1 and 2). J Cataract Refract Surg 50(1):57\u201363. https:\/\/doi.org\/10.1097\/j.jcrs.0000000000001313","journal-title":"J Cataract Refract Surg"},{"key":"7184_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-016-0065-3","volume":"3","author":"A Almamoun","year":"2016","unstructured":"Almamoun A, Herbert EK (2016) Clinical outcomes of combined versus separate carbachol and brimonidine drops in correcting presbyopia. Eye Vis 3:31. https:\/\/doi.org\/10.1186\/s40662-016-0065-3","journal-title":"Eye Vis"},{"issue":"10","key":"7184_CR18","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1016\/j.ophtha.2018.04.013","volume":"125","author":"TR Fricke","year":"2018","unstructured":"Fricke TR, Tahhan N, Resnikoff S et al (2018) Global prevalence of presbyopia and vision impairment due to uncorrected presbyopia: A systematic review, meta-analysis, and modeling. Ophthalmology 125(10):1492\u20131499. https:\/\/doi.org\/10.1016\/j.ophtha.2018.04.013","journal-title":"Ophthalmology"},{"issue":"S1","key":"7184_CR19","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.3928\/1081597X-20210408-06","volume":"37","author":"RN Mercer","year":"2021","unstructured":"Mercer RN, Milliken CM, Waring GO et al (2021) Future trends in presbyopia correction. J Refract Surg 37(S1):S28\u2013S34. https:\/\/doi.org\/10.3928\/1081597X-20210408-06","journal-title":"J Refract Surg"},{"key":"7184_CR20","doi-asserted-by":"publisher","unstructured":"AJ, Jaya G, Yumna S et al (2022) In Vitro and in-eye comparison of commercial pilocarpine ophthalmic solution and an optimized, reformulated pilocarpine for presbyopia treatment. Ophthalmol Ther 11(2):869\u2013879. https:\/\/doi.org\/10.1007\/s40123-022-00482-2","DOI":"10.1007\/s40123-022-00482-2"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07184-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07184-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07184-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:53:26Z","timestamp":1789455206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07184-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["7184"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07184-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained from the Institutional Review Board of Shanxi Ophthalmology Hospital (SXYYLL-20240310).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}